Wanbury profitability ratios

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Returns
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
64.9%64.9%70.0%294.0%410.0%
14.2%14.2%8.1%9.4%−3.2%
33.3%33.3%34.2%82.3%119.2%
23.4%25.8%27.6%41.8%19.5%
Margins
15.1%16.4%12.7%12.2%4.6%
14.2%14.2%10.5%9.9%2.2%
—58.0%25.3%60.8%—
7.8%9.2%4.9%5.3%−2.1%
8.6%10.2%5.1%5.3%−2.1%
−4.2%−4.2%−3.8%0.7%4.0%
Additional
−10.0%−10.6%−3.3%1.2%−1.1%
—0.0%0.0%10.3%0.0%
64.9%64.9%70.0%263.6%410.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

WANBURY₹181.93

Wanbury Limited

· Pharma & Health
₹ CrorePeersAHCLANUHPHRBAJAJHCARETHEMISMEDZIMLABLINCOLNSIGACHIVALIANTLABMcap ₹636 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity409.98293.9770.0164.9364.93
Return on Assets-3.189.428.0614.2014.20
Return on Capital Employed119.1782.3134.1833.2633.26
Return on Invested Capital19.4641.8327.6025.8023.40
Margins
EBITDA Margin4.6412.1612.7316.4215.10
Operating Margin2.169.9010.5114.2214.22
Incremental Operating Margin—60.7725.3058.00—
Pretax Margin-2.065.354.939.207.78
Net Income Margin-2.085.285.0910.178.56
FCF Margin3.960.70-3.82-4.23-4.23
Additional
Effective Tax Rate-1.061.24-3.31-10.59-10.05
Dvd Payout Ratio-0.0010.330.000.00—
Sustainable Growth Rate409.98263.6170.0164.9364.93
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.